S100A8 and hepatocellular carcinoma: The serum levels of three members were higher from either HBV-negative or -positive HCC patients than that from healthy controls (HCs), while serum levels of S100A9 but not S100A8 and S10012 were higher from HBV-positive HCC patients than that from HBV-negative HCC patients.